The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.
Peripheral reduction of β-amyloid is sufficient to reduce brain β-amyloid: Implications for Alzheimer's disease
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The BBB participates in the regulation of the brain pool of Aβ peptides and the re-entry of these peptides into the brain.
“The BBB also participates in the regulation of the brain pool of A peptides in general and the re-entry of these peptides into the brain in particular [32][33][34][35][36].”
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Immunization with amyloid-β attenuates Alzheimer-disease-like pathology in the PDAPP mouse
Schenk, D., Barbour, R., Dunn, W., Gordon, G., Grajeda, H., Guido, T., Hu, K., Huang, J., Johnson-Wood, K., Khan, K., et al. (1999) · Nature · doi:10.1038/22124 · Cited by 3,160
Kawarabayashi, T., Younkin, L. H., Saido, T. C., Shoji, M., Ashe, K. H., & Younkin, S. G. (2001) · The Journal of Neuroscience · doi:10.1523/jneurosci.21-02-00372.2001 · Cited by 1,053 · cited 1×
“The plasma fraction was removed and stored at –808C. Brains were removed, frozen rapidly on dry ice, and stored at –808C. Oligomeric Ab was extracted in the SDS fraction essentially as described by Kawarabayashi et al. (2001).”
Method
Flagged first, then by citations
Research works printed but not linked: 26
- Barten, 2008, Therapeutic strategies for Alzheimer's disease, Mol Neurobiol, 37, 171, 10.1007/s12035-008-8031-2 · DOI
- Bassez, 2004, Pleiotropic and diverse expression of ZFHX1B gene transcripts during mouse and human development supports the various clinical manifestations of the “Mowat-Wilson” syndrome, Neurobiol Dis, 15, 240, 10.1016/j.nbd.2003.10.004 · DOI
- Blazejczyk, 2006, Ca2+-independent binding and cellular expression profiles question a significant role of calmyrin in transduction of Ca2+ signals to Alzheimer's disease-related presenilin 2 in forebrain, Biochim Biophys Acta, 1762, 66, 10.1016/j.bbadis.2005.09.006 · DOI
- Cheung, 2008, Mechanism of Ca2+ disruption in Alzheimer's disease by presenilin regulation of InsP3 receptor channel gating, Neuron, 58, 871, 10.1016/j.neuron.2008.04.015 · DOI
- Gatti, 2007, Genome-level analysis of genetic regulation of liver gene expression networks, Hepatology, 46, 548, 10.1002/hep.21682 · DOI
- He, 2010, Gamma-secretase activating protein is a therapeutic target for Alzheimer's disease, Nature, 467, 95, 10.1038/nature09325 · DOI
- Hustinx, 2004, Differentially expressed genes in pancreatic ductal adenocarcinomas identified through serial analysis of gene expression, Cancer Biol Ther, 3, 1254, 10.4161/cbt.3.12.1238 · DOI
- Ishigaki, 2002, Two novel genes, human neugrin and mouse m-neugrin, are upregulated with neuronal differentiation in neuroblastoma cells, Biochem Biophys Res Commun, 279, 526, 10.1006/bbrc.2000.3971 · DOI
- Isohata, 2009, Hedgehog and epithelial-mesenchymal transition signaling in normal and malignant epithelial cells of the esophagus, Int J Cancer, 125, 1212, 10.1002/ijc.24400 · DOI
- Kulnane, 2001, Neuropathological characterization of mutant amyloid precursor protein yeast artificial chromosome transgenic mice, Neurobiol Dis, 8, 982, 10.1006/nbdi.2001.0446 · DOI · Paper page
- Lehman, 2003, Genetic background regulates beta-amyloid precursor protein processing and beta-amyloid deposition in the mouse, Hum Mol Genet, 12, 2949, 10.1093/hmg/ddg322 · DOI · Paper page
- Netzer, 2003, Gleevec inhibits beta-amyloid production but not Notch cleavage, Proc Natl Acad Sci U S A, 100, 12444, 10.1073/pnas.1534745100 · DOI
- Ryman, 2008, Genetic loci modulating amyloid-beta levels in a mouse model of Alzheimer's disease, Neurobiol Aging, 29, 1190, 10.1016/j.neurobiolaging.2007.02.017 · DOI
- Selkoe, 2001, Alzheimer's disease: genes, proteins, and therapy, Physiol Rev, 81, 741, 10.1152/physrev.2001.81.2.741 · DOI · Paper page
- Stabler, 1999, A myristoylated calcium-binding protein that preferentially interacts with the Alzheimer's disease presenilin 2 protein, J Cell Biol, 145, 1277, 10.1083/jcb.145.6.1277 · DOI
- Takayama, 2002, Imatinib mesylate has limited activity against the central nervous system involvement of Philadelphia chromosome-positive acute lymphoblastic leukaemia due to poor penetration into cerebrospinal fluid, Br J Haematol, 119, 106, 10.1046/j.1365-2141.2002.03881.x · DOI
- Tanzi, 1989, Molecular genetics of Alzheimer's disease and the amyloid beta peptide precursor gene, Ann Med, 21, 91, 10.3109/07853898909149191 · DOI
- Terry, 2006, Alzheimer's disease and the aging brain, J Geriatr Psychiatry Neurol, 19, 125, 10.1177/0891988706291079 · DOI
- Verstappen, 2008, Atypical Mowat-Wilson patient confirms the importance of the novel association between ZFHX1B/SIP1 and NuRD corepressor complex, Hum Mol Genet, 17, 1175, 10.1093/hmg/ddn007 · DOI
- Wang, 2003, WebQTL: web-based complex trait analysis, Neuroinformatics, 1, 299, 10.1385/NI:1:4:299 · DOI
- Waring, 2008, Genome-wide association studies in Alzheimer disease, Arch Neurol, 65, 329, 10.1001/archneur.65.3.329 · DOI
- Williams, 2007, Cytokine-dependent imatinib resistance in mouse BCR-ABL +, Arf-null lymphoblastic leukemia, Genes Dev, 21, 2283, 10.1101/gad.1588607 · DOI
- White, 2006, CIB1, a ubiquitously expressed Ca2+-binding protein ligand of the InsP3 receptor Ca2+ release channel, J Biol Chem, 281, 20825, 10.1074/jbc.M602175200 · DOI
- Wolfe, 2006, The gamma-secretase complex: membrane-embedded proteolytic ensemble, Biochemistry, 45, 7931, 10.1021/bi060799c · DOI · Paper page
- Wolff, 2003, The CNS is a sanctuary for leukemic cells in mice receiving imatinib mesylate for Bcr/Abl-induced leukemia, Blood, 101, 5010, 10.1182/blood-2002-10-3059 · DOI
- Zweier, 2002, “Mowat-Wilson” syndrome with and without Hirschsprung disease is a distinct, recognizable multiple congenital anomalies-mental retardation syndrome caused by mutations in the zinc finger homeo box 1B gene, Am J Med Genet, 108, 177, 10.1002/ajmg.10226 · DOI
Cited by
Sorted by citations
Neurovascular pathways to neurodegeneration in Alzheimer’s disease and other disorders
Zlokovic, B. V. (2011) · Nature Reviews Neuroscience · doi:10.1038/nrn3114 · Cited by 2,969
Deane, R., Singh, I., Sagare, A. P., Bell, R. D., Ross, N. T., LaRue, B., Love, R., Perry, S., Paquette, N., Deane, R. J., et al. (2012) · Journal of Clinical Investigation · doi:10.1172/jci58642 · Cited by 619
Neurovascular Dysfunction and Faulty Amyloid -Peptide Clearance in Alzheimer Disease
Sagare, A. P., Bell, R. D., & Zlokovic, B. V. (2012) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a011452 · Cited by 251
Erickson, M. A., Hartvigson, P. E., Morofuji, Y., Owen, J. B., Butterfield, D. A., & Banks, W. A. (2012) · Journal of Neuroinflammation · doi:10.1186/1742-2094-9-150 · Cited by 145
Is Alzheimer’s Disease a Liver Disease of the Brain?
Bassendine, M. F., Taylor-Robinson, S. D., Fertleman, M., Khan, M., & Neely, D. (2020) · Journal of Alzheimer's Disease · doi:10.3233/jad-190848 · Cited by 124
The pericyte–glia interface at the blood–brain barrier
Giannoni, P., Badaut, J., Dargazanli, C., De Maudave, A. F., Klement, W., Costalat, V., & Marchi, N. (2018) · Clinical Science · doi:10.1042/cs20171634 · Cited by 81
Lam, V., Takechi, R., Hackett, M. J., Francis, R., Bynevelt, M., Celliers, L. M., Nesbit, M., Mamsa, S., Arfuso, F., Das, S., et al. (2021) · PLOS Biology · doi:10.1371/journal.pbio.3001358 · Cited by 80
Su, Q., Li, T., He, P.-F., Lu, X.-C., Yu, Q., Gao, Q.-C., Wang, Z.-J., Wu, M.-N., Yang, D., & Qi, J.-S. (2021) · Alzheimer's Research & Therapy · doi:10.1186/s13195-020-00746-8 · Cited by 75
Han, S.-H., Park, J.-C., & Mook-Jung, I. (2016) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2015.12.004 · Cited by 67
Kuntz, M., Candela, P., Saint-Pol, J., Lamartinière, Y., Boucau, M.-C., Sevin, E., Fenart, L., & Gosselet, F. (2015) · Journal of Alzheimer's Disease · doi:10.3233/jad-150469 · Cited by 55
Urayama, A., Moreno-Gonzalez, I., Morales-Scheihing, D., Kharat, V., Pritzkow, S., & Soto, C. (2022) · Molecular Psychiatry · doi:10.1038/s41380-022-01679-4 · Cited by 37
Gardner, L. E., White, J. D., Eimerbrink, M. J., Boehm, G. W., & Chumley, M. J. (2016) · Neuroscience · doi:10.1016/j.neuroscience.2016.06.007 · Cited by 29
Metadata
- Authors
- Sutcliffe, J. G., Hedlund, P. B., Thomas, E. A., Bloom, F. E., & Hilbush, B. S.
- Venue
- Journal of Neuroscience Research
- Publisher
- Wiley
- Published
- 2011-03-03
- Volume
- 89
- Issue
- 6
- Pages
- 808-814
- ISSN
- 0360-4012
- Cited by
- 105
- References
- 2
- Language
- en
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
